Clinical trial
A Single-dose, Open Labeled, Multicenter Phase IIa Clinical Study on the Efficacy and Safety of Sulcardine Sulfate Tablets in Patients With Premature Ventricular Contractions
NCT01235156 is registered in ClinicalTrials.gov with Jiangsu Furui Pharmaceuticals Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-dose, Open Labeled, Multicenter Phase IIa Clinical Study on the Efficacy and Safety of Sulcardine Sulfate Tablets in Patients With Premature Ventricular Contractions
- Lead sponsor
- Jiangsu Furui Pharmaceuticals Co., Ltd
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2010
- Completion date
- Not reported
- Enrollment
- 36 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
premature ventricular contraction